8 in 10 are satisfied with Lactium, a natural bioactive developed by Ingredia

Following nine clinical studies that were performed on more than 500 people in 2021, Ingredia wanted to address a core objective for all its customers: consumer satisfaction. To do so, the company: 

• Recruited 300 persons worldwide, in three distinct regions – the US, France and China
• Applied a strict methodology with validated questionnaires and partnered with BioMerieux, utilising the company’s expertise in the area
  
• Asked 300 participants to try Lactium at 300mg/day, reporting on either their stress indication or sleep disturbance indication.

The results are now in and Ingredia is proud to announce an overall 78% satisfaction, quite evenly split – 78% in the stress indication and 77% in the sleep disturbance indication.

Join us during Vitafoods Europe on 10-12 May, booth G100.

To find out more about Lactium, contact us: lactium.com/contact